• Ophthalmic Business Council

    For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.

    OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.

    To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.

    Download brochures: AAO 2019 exhibitors and non-exhibitors

    Save the Date

    Fall 2020 Symposium
    Sept. 10 to 11, 2020
    San Francisco, Calif.

    Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.

    Spring 2021 Symposium
    April 22, 2021
    Washington, DC

    Held every other year, the Spring Symposium focuses on the latest first-hand from experts on FDA, Medicare and reimbursement issues. As the speed of innovation grows, this event helps you navigate the complexities of introducing new technologies and treatments to patients. Unlike the Fall Symposium, Academy leaders do not attend this meeting.



    Member Benefits

    2019 - 2020 Ophthalmic Business Council 

    Platinum Benefactors ($35,000)
    Novartis Pharmaceuticals
    Crown Benefactors ($25,000)
    Alcon, Inc.
    Allergan, Inc.
    Carl Zeiss Meditec, Inc.
    Genentech, Inc.
    Johnson & Johnson Vision
    Mallinckrodt Pharmaceuticals
    Optos, Inc.
    Regeneron Pharmaceuticals, Inc.

    Benefactors ($15,000)
    Bausch + Lomb
    Horizon Pharma
    Verana Health

    Patrons ($7,500)
    Aerie Pharmaceuticals, Inc.
    Allegro Ophthalmics
    Boehringer Ingelheim
    EyePoint Pharmaceuticals
    Glaukos Corporation
    Kala Pharmaceuticals, Inc.
    Leadiant Biosciences, Inc.
    Santen, Inc.

    Subscribers ($5,000)
    Biogen, Inc.
    Bio-Tissue, Inc.
    Heidelberg Engineering
    Nevakar, Inc.
    Omeros Corporation
    Spark Therapeutics, Inc.
    W. L. Gore & Associates

    Members ($2,500)
    Apellis Pharmaceuticals
    Aura Biosciences, Inc.
    Clearside Biomedical, Inc.
    NeoMedix Corporation
    New World Medical, Inc.
    Ocunexus Therapeutics
    Sun Ophthalmics